Vera Therapeutics (VERA) had the highest return between January 15, 2024 and January 30, 2024 by a small-cap US stock, returning 88.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/15/2024 - 1/30/2024 | 88.07% |
Edgewise Therapeutics (EWTX) | 1/15/2024 - 1/30/2024 | 75.46% |
Eos Energy Enterprises (EOSEW) | 1/15/2024 - 1/30/2024 | 63.64% |
Arcutis Biotherapeutics (ARQT) | 1/15/2024 - 1/30/2024 | 60.82% |
Dianthus Therapeutics (DNTH) | 1/15/2024 - 1/30/2024 | 59.9% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/15/2024 - 1/30/2024 | 54.61% |
Purecycle Technologies (PCT) | 1/15/2024 - 1/30/2024 | 52.21% |
Eos Energy Enterprises (EOSE) | 1/15/2024 - 1/30/2024 | 43.75% |
Innodata (INOD) | 1/15/2024 - 1/30/2024 | 41.64% |
Compass Pathways (CMPS) | 1/15/2024 - 1/30/2024 | 38.45% |
Cullinan Oncology LLC (CGEM) | 1/15/2024 - 1/30/2024 | 37.62% |
Kura Oncology (KURA) | 1/15/2024 - 1/30/2024 | 37.26% |
Immunome (IMNM) | 1/15/2024 - 1/30/2024 | 37.04% |
Oric Pharmaceuticals (ORIC) | 1/15/2024 - 1/30/2024 | 35.02% |
Enliven Therapeutics (ELVN) | 1/15/2024 - 1/30/2024 | 34.43% |
American Superconductor (AMSC) | 1/15/2024 - 1/30/2024 | 33.86% |
Codere Online US (CDRO) | 1/15/2024 - 1/30/2024 | 33.64% |
Clene (CLNNW) | 1/15/2024 - 1/30/2024 | 33.56% |
Neuropace (NPCE) | 1/15/2024 - 1/30/2024 | 33.33% |
Viant Technology (DSP) | 1/15/2024 - 1/30/2024 | 33.14% |
GH Research (GHRS) | 1/15/2024 - 1/30/2024 | 30.63% |
Akso Health Group ADR (AHG) | 1/15/2024 - 1/30/2024 | 30% |
Dyne Therapeutics (DYN) | 1/15/2024 - 1/30/2024 | 29.3% |
Intuitive Machines (LUNR) | 1/15/2024 - 1/30/2024 | 28.79% |
Spyre Therapeutics (SYRE) | 1/15/2024 - 1/30/2024 | 28.67% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
